Clinical Management of Diffuse Low-Grade Gliomas

Area of Science:

• Neuro-oncology
• Molecular Pathology
• Radiology

Background:

• Diffuse low-grade gliomas (LGG) are heterogeneous primary brain tumors affecting young adults.
• Advances in molecular profiling (IDH mutations, 1p/19q codeletion) and neuroradiology aid LGG diagnosis and prognosis.
• Optimal post-operative management for LGG remains a clinical challenge.

Purpose of the Study:

• To review recent research on clinical and molecular characteristics of diffuse low-grade gliomas.
• To discuss advancements in neuroradiological techniques for LGG assessment.
• To explore current and emerging therapeutic strategies, including personalized targeted therapy and supportive care for LGG.

Main Methods:

• Comprehensive literature review of recent studies on diffuse low-grade gliomas.
• Analysis of clinical data, molecular profiles, and imaging techniques.
• Synthesis of information on treatment modalities and supportive care.

Main Results:

• Molecular markers like IDH mutations and 1p/19q codeletion are crucial for LGG stratification.
• Neuroradiological techniques offer improved diagnostic and follow-up capabilities for LGG.
• Radiation therapy and chemotherapy are established post-operative treatments, with emerging targeted therapies showing promise.

Conclusions:

• Personalized treatment approaches are essential for managing diffuse low-grade gliomas.
• Continued research into molecular features and novel therapies will improve LGG patient outcomes.
• Multidisciplinary care, including supportive measures, is vital for LGG management.